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he main goal of this study was to histologically evaluate the healing of surgically created defects on the tibiae of adult male
rats after implantation of two types of bioactive glass. Sixteen adult Wistar rats (body weight of 300g) were divided into two
groups: PerioGlas (PG) (n=8) and BioGran (BG) (n=8). Unicortical bone defects with 3-mm diameter were performed in both
tibiae of the animals and filled with two types of glass particles. The rats were then sacrificed at 7, 14, 30 and 60 days, and the
tissues were prepared for histological processing, sectioning, and staining with hematoxylin and eosin, as well as Mallory
trichrome, and analyzed under light microscope. Within 7-14 days, both groups presented connective tissue septa with new
bone formation, more intense in the PG group. In the subsequent periods (30 and 60 days), both groups presented more mature
bone tissue around the glass particles. Bone trabeculae formed in all experimental periods were juxtaposed to the glass
particles. It can be concluded that both materials promoted comparable bone formation over the entire extension of the defect,
independently of the size of the granules, thus confirming their biological osteoconductive property.
UNITERMS: Bone regeneration; Bioactive ceramic; Bone repair; Implant; Bioactive glass.
   objetivo deste estudo foi avaliar a resposta histológica após a implantação de dois tipos de cerâmicas bioativas em
defeitos criados na tíbia de ratos. Dezesseis ratos da raça Wistar, pesando 300g, foram divididos em dois grupos: PerioGlass
(PG) (n=8) e Biogran (BG) (n=8). Defeitos ósseos unicorticais de 3 mm de diâmetro foram realizados na tíbia dos animais e
preenchidos com os dois tipos de partículas cerâmicas. Os animais foram sacrificados aos 7, 14, 30 e 60 dias no pós-operatório.
O material preparado para processamento e exame histológico em microscopia óptica foi corado com hematoxilina-eosina e
tricrômio de Mallory. Aos 7 dias ambos os grupos apresentaram septos ósseos neoformados, mais intensos no grupo PG. Isto
também foi observado aos 14 dias. Nos períodos posteriores (30 e 60 dias), ambos os grupos apresentaram tecido ósseo mais
maduro ao redor das partículas cerâmicas. As trabéculas ósseas formadas em todos os períodos experimentais foram justapostas
com as partículas. Podemos concluir que ambos os materiais promoveram o preenchimento ósseo em toda a extensão do
defeito independente de suas granulações comprovando suas propriedades osteocondutivas.
UNITERMOS: Regeneração óssea; Cerâmica bioativa; Reparação óssea; Implante; Biogran.
INTRODUCTION
The autogenous material is still the best choice for
reconstruction of bone defects (Boyne2 ,1997; Vasconcelos,
et al.25 , 1998). However, this type of graft involves additional
surgical trauma to the patient and very often cannot be
obtained in sufficient amount to fill the whole defect;
moreover, not all patients will accept to undergo surgery for
removal of donor material from the iliac crest, tibia or skull.
The interest in the development and use of a synthetic
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material has led to the development of several studies
evaluating the results of the utilization of hydroxyapatite
(HA) as a bone tissue substitute (Jarcho, et al.8, 1986;
Mellonig, et al.14, 1991; Kenney, et al.11, 1985; Novaes Jr., et
al.16, 1990). Clinical and histological studies have shown
involvement of HA granules with the connective tissue,
with no incorporation in the neighboring bone tissue, in
addition to a more prominent inflammatory response with
this type of alloplastic material (Salata, et al.20, 1998). The
treatment of localized atrophies of the alveolar ridge with
masticatory membrane autogenous grafting and
hydroxyapatite implants presents some drawbacks and
technical problems (Seibert, Nyman22, 1990).
The use of allogenic materials has been discussed due
to the possibility of disease transmission, small amount of
bone morphogenetic protein, and also due to non-vital bone
particles remaining inside the repaired defect (Becker, et al.1;
1994; Low, et al.12, 1997). Results obtained in studies using
biomaterials have presented controversial data, which due
to a lack of information may lead professionals to use
materials that do not produce the expected advantages after
treatment of several kinds of bone defects.
Application of the biological principles of guided bone
regeneration has rendered interesting results in minor
osseous defects (Macedo, et al.13, 1993; Buser, et al.3, 1995;
Jovanovic, et al.9, 1995). Nevertheless, membrane exposition
can occur and its consequent contamination may produce
local infection, thus hindering the desired new bone
formation.
Unexpected results due to the use of the materials and
techniques mentioned above have directed technological
advances to recent studies with some bio-active materials
to be used as bone substitutes, in several kinds of defects
in the field of Dentistry. Bioactive glass has shown the ability
to help bone regeneration and clinical insertion gain, with
better results than other materials available (Wilson, Low27,
1992; Low, et al.12, 1997; Turunen, et al.24, 1997; Zamet, et
al.30, 1997; Shapoff, et al.23, 1997).
This material has also demonstrated osteoconductive
and osteopromotive abilities in the biocompatible interface
for osseous migration, and a bioactive surface colonized by
osteogenic cells free in the surgical wound (Schepers, et
al.21, 1991, Wilson, Low27, 1992). Their ability to bond to soft
and osseous tissues seems to make a difference when
compared to other alloplastic materials available (Wilson, et
al.26, 1993, Hench, et al.6, 1973, Hench, et al.7, 1971). Zamet,
et al.30, 1997, have evaluated the effects of a bioactive glass
(PerioGlas) in the treatment of intrabony periodontal defects
with a higher reduction of probing depth when compared to
conventional treatments.
Such findings are in agreement with those of Low, et
al.12,1997, who demonstrated clinical attachment gain and
probing depth reduction after implantation of this bioactive
glass in bone defects. The use of BioGlass particles promotes
a much faster proliferation of new bone tissue, comparable
to that occurring after the use of autogenous bone graft;
furthermore, the combination of BioGlass granules and
autogenous bone results in more bone growth when
compared to the autogenous material (Oonishi, et al.17, 1997).
Based on these facts, this comparative experimental
study has histologically evaluated the bone tissue response,
and its regenerative potential in the healing of bone defects
created in rat tibiae following implantation of two types of
bioactive glass particles.
MATERIAL AND METHODS
In the present study, 16 male rats (Rattus norvegicus,
albinus, Wistar) weighing 300g were used, which were fed a
solid diet before and during the experimental period (Moinho
Primor SA, Brazil) and received water ad libitum. The entire
experimental study was carried out according to the Ethics
Principles on Animal Experiments of São José dos Campos
Dental School, UNESP.
Bone Substitutes
Two kinds of synthetic resorbable materials, in the form
of granules - PerioGlas (US Biomaterials Corporation,
Alachua, Florida, USA) and Biogran (Orthovita, Malvern,
PA, USA) were used for treatment of the bone defects. Both
bioactive glass materials present the same chemical
composition - 45% silicon dioxide (SiO2), 24.5% calcium oxide
(CaO), 24.5% sodium oxide (NaO2), and 6% phosphorus
pentoxide (P2O5) - differing only in the diameter of the
granules. Biogran presents more regular granules - 300 to
355ìm, whereas Perioglas has more irregular granules,
ranging from 90 to 710ìm. Eight animals were employed for
each material.
Surgical Procedure
Before surgery, the animals were weighed for a correct
calculation of the anesthetic dosage. General anesthesia
was used with intramuscular application of a sedative
solution - hydrochloride 2-(2.6 xylidine)-5.6-dyhidro-4H-1.3-
thiazine (Rompum, Bayer do Brasil), and ketamine anesthetic
1.0g (Francotar, Virbaxil, Virbac do Brasil Indústria e Comércio
Ltda., São Paulo, Brazil), in the proportion of 1:0.5ml in the
0.1ml/100g of body weight.
After trichotomy and asepsis of the surgical field with
iodine, the lateral and superior aspects of the tibiae in both
posterior paws were exposed with a 1.5-cm long incision,
using a #15 interchangeable blade, on a Bard-Parker scalpel.
Tissue separation was performed with periosteum
elevators and a Molt elevator, so as to obtain a
mucoperiosteal flap to expose the bone tissue and allow
free access to create osseous defects. In both paws, a
monocortical bone defect measuring 3mm in diameter was
prepared with Asseptico electric engine (AEU-707-MGF
Asseptico Inc., USA), using a 1/16 reduction, straight tip,
trephine drills, at a speed of 1500rpm, under copious irrigation
with 0.9% sterile saline solution throughout the bone
manipulation. Before placing bone filling glass materials,
the bone cavities were irrigated with antibiotic (Rifocina M,
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Lepetit SA, São Paulo, Brazil), in the proportion of 75 mg/
20ml sterile saline.
On the right posterior paw, PerioGlas (PG) granules were
placed to fill the defect; on the left paw, the defect was filled
with BioGran (BG) granules, carefully in order to avoid
excessive filling. Both materials were prepared just before
being used, 0.9% sterile saline solution was added to the
flasks, sterilized with gamma rays provided by the
manufacturer, until a paste-like texture was obtained.
The flaps were closed with 4-0 silk intermittent sutures
(Ethicon, Jonhson & Johnson) and deeper planes were
closed with absorbable Vicryl 4-0 suture (Ethicon, Johnson
& Johnson).
Immediately after the surgical procedure, all animals
received intramuscular application of antibiotics and anti-
inflammatory (Agrovet Plus, Ciba-Geigy Química, SA, São
Paulo, Brazil), in the dosage of 0.2ml/kg of body weight.
Histological Study
The animals were sacrificed with an overdose of
anesthetic at 7, 14, 30 and 60 days after the surgical
procedures. After removal of soft tissues, bone fragments
including the implanted material were obtained and fixed in
a 10% formalin solution for at least 48 hours. Decalcification
was accomplished in 20% sodium citrate and 50% formic
acid solution, 1:1. Tthe decalcified samples were embedded
in paraffin and 6-µm thick semi-serial sections were obtained
and stained with hematoxylin-eosin and Mallory trichrome
for light microscopy analysis.
RESULTS
After seven days, the spaces filled by particles of
implanted materials showed varying sizes and were
surrounded by granulation tissue and thin woven bone
trabeculae. Some of the trabeculae were lamellar and were
associated with marrow tissue. That aspect could be seen
up to the center of the surgical defect, extending inside the
marrow space. Some particle spaces were divided by thin
bone septa on the inside, dividing them into smaller portions.
New bone formation was observed next to the defect
borders, with newly formed trabeculae covered by
osteoblasts, both facing the periosteum and inside the
medullar channel (Figures 1 and 2).
After 14 days, bone trabeculae surrounding the spaces
taken up by implanted particles were more mature and
interspersed with bone marrow. On the surgical defect
margins, basophilic lines could be observed inside the bone
tissue, which indicates a remodeling process. Mild signs of
excavated internal pouches of granules could be seen, which
would function as sites to stimulate new bone formation
(Figure 3).
After 30 days, bone trabeculae surrounding the spaces
of the particles were thicker and more mature than in the
previous stages, which showed signs of remodeling, as
occurred on the surgical defect borders, and were
interspersed with bone marrow. In some spaces, bone tissue
formed in their excavations was observed in addition to thin
bone septa. Other spaces presented delicate fibrilar material,
sometimes with a reticular aspect (Figures 4 and 5).
After 60 days, bone trabeculae surrounding the spaces
taken up by particles were thicker, with a lamellar aspect,
and were interspersed with bone marrow. Inside some of the
spaces, a remaining structure from the implanted material
was found integrated to the bone tissue, besides thin bone
septa. These spaces showed a material with delicate fibrilar
aspect, occasionally with a reticular appearance. There was
bone growth inside granules in both materials, with
indications of bone remodeling (Figures 6, 7, and 8).
FIGURE 1- Biogran (BG) 7 days. Spaces taken up by glass
particles of varying sizes (A); thin bone trabeculae, some
of them with lamellar aspect and marrow tissue. Some
spaces are subdivided by thin bone septa, new bone
formation next to defect margins (B), facing the periosteum
and the inner part of the marrow space. Mallory trichrome.
Magnification 25x
FIGURE 2- Perioglass (PG) 7 days. Spaces filled with glass
particles of varying sizes, encircling granulation tissue;
immature bone trabeculae (A); scarce mononuclear
inflammatory infiltrate. There are newly formed bone
trabeculae next to the defect margins, surrounded by
osteoblasts. Sub-periosteal new bone formation, next to
the defect (B).  HE. Magnification 100x
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DISCUSSION
The main goal when treating bone defects is regeneration
of the bone tissue destroyed by diseases, traumas, etc.
Frequently, guided bone regeneration techniques have been
used as well as autogenous, xenogenic and allogenic bone
grafts, and alloplastic materials that ideally would have good
osteoinductive potential, which causes minimal inflammatory
reactions, rapid vascularization, affinity with host tissues,
easy accessibility, and should be inexpensive (Park, et al.18,
2001).
Although autogenous bone grafts are considered the
best and most widely accepted material for treatment of bone
defects, it requires an additional surgery on the donor area,
and many times it cannot be found in sufficient amounts for
complete filling of the lesion, thus leading to the search for
substitute materials. The allogenic bone can cause a
sustained inflammatory response; furthermore, there is a
possibility of disease transmission.
Certain glass materials, such as tricalcium phosphate,
hydroxyapatite, and calcium carbonate, have been used.
Tricalcium phosphate presents low osteoinductivity and is
rapidly reabsorbed. Some types of hydroxyapatite are
encapsulated by the connective tissue and therefore they
do not allow true bone tissue regeneration. Recently, clinical
applications of bioactive glass in dentistry have become a
common practice. On the initial implantation stage, they
bond to the bone tissue, inhibiting fibroblastic growth.
Materials tested in this study consisted of 45% SiO2, 24.5%
CaO, 24.5% NaO2, and 6% P2O5, for maximum bone affinity
and osseointegration. The particles pack into bone holes
easily and stay in place, even when the surgical wound is
bleeding.
According to the manufacturer, the particles of Biogran
form a protective vesicle, as a central mushroom-type,
starting with fissure formation acting as an osteogenesis
nucleus, which confers osteoconductive properties. These
particle fissures and pores allow optimum space for
vascularization. This material is easy to handle and has
hemostatic effect and high biocompatibility. Schepers, et
al.21, 1991, studied the osteogenesis stimulated by bioactive
glass and showed that the ionic exchange on the interface
between particles and tissue fluids forms a silica gel layer
which is rich in Ca and P.
Cordioli, et al.4, 2001, used bioactive glass granules
(Biogran) in combination with autogenous bone in surgeries
for maxillary sinus elevation in patients with three to five
millimeter bone height at the alveolar ridge, which showed a
predictable surgical procedure with achievement of good
quality and adequate bone volume. Our results histologically
confirm that the bioactive glass particles showed
osteoconductive and osseointegration properties, as
FIGURE 3- PG 14 days. Larger amount of bone tissue
around the particle spaces, with mature aspect (A); bone
marrow between trabeculae; remodeling basophilic lines
inside the bone tissue (B). HE. Magnification 100x
FIGURE 4 - BG 30 days. Bone trabeculae surrounding the
spaces taken up by glass particles are thicker and more
mature (A), with indications of remodeling, as on defect
margins, and interspersed with bone marrow. Thin bone
septa are found inside the spaces (B). Fibrilar aspect has
also been found in this group. HE. Magnification 100x
FIGURE 5 - PG 30 days. Spaces filled with particles
surrounded by more mature bone tissue; indications of
remodeling (A). In some of the spaces, the presence of
bone tissue (B) can be observed (apparently formed inside
them), as well as thin bone septa. Delicate fibrilar material
inside other spaces, occasionally with reticular aspect.
Bone trabeculae interspersed with bone marrow. Bone
growth can be observed inside the granule. HE.
Magnification 400x
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documented by the close contact between the material and
the newly formed bone, as well as bone growth around them
and inside the granules. Both materials presented
transformed particles and were smaller than the original,
due to partial dissolution through ionic exchange with tissue
fluids. At the final stage of evaluation, the histological
material showed areas with osteoid tissue (bone tissue being
formed), which would call for a longer time for bone
maturation and complete resorption of the material with bone
replacement.
According to Moore, et al.15, 2001, bioactive glass
granules are more quickly reabsorbed than hydroxyapatite,
thus allowing a much more precocious new bone formation
in the repair of bone defects. On them, osteoblasts show
several cytoplasmic processes, pseudopodia, compact
appearance, and disorderly dorsal surface, which
characterize a high cell membrane activity. Therefore, as to
the adhesion and close contact between osteoblasts,
bioactivity should be considered crucial to the development
of new bases for bone tissue bioengineering. Its use in
medical and dental areas, due to the excellent
biocompatibility and its physical and chemical properties,
has encouraged studies on the feasibility of implant coating,
so as to obtain better biologic fixation, and also as a carrier
of osteoinductive substances, such as bone morphogenetic
proteins and other growth factors (Keeting, et al.10, 1992;
Price, et al.19, 1997; Hamadouche, Sedel5, 2000). Turunen, et
al.24, 1997, also demonstrated the effectiveness of bioactive
glass, as they improved the osseointegration of coated
implants, provided better bone support, and presented
increased stability when compared to machined implants.
Glass particles, when in contact with body fluids, trigger
three reactions: diffusion, dissolution, and precipitation.
Initially, an ionic exchange occurs between the particles and
the solution, where sodium separates from glass and is
replaced by protons from the environment. This way, the
pH of the wound raises to neutral, creating good conditions
for repair. Together with the diffusion reaction, there is
dissolution of the glass silica weave, on which hydroxyl
groups in oxygen and silica bonds are attacked, releasing
silicic acid. When this acid is released, silanol groups form
a hydrated layer on the glass surface. Through a
polycondensation reaction, the silanol groups undergo re-
grouping, making up silica gel (Shapoff, et al.23, 1997). This
layer will provide the main property of the material - bonding
both to hard tissues and soft tissues (Yilmaz, et al.28, 1998).
That bond occurs through bioactive fixation, involving
collagen fibers inside the polycrystalline matrix on the
implanted material surface induced by the carbonated apatite
layer. The quick surface reaction of the material, and the
formation of a calcium phosphate hydrated layer biologically
active on its surface, are responsible for the fast bone
formation. The gel layer, rich in silica, has a wide surface
area, negatively charged, which works as a nucleation site
to the formation of a calcium phosphate layer. This stage is
initially amorphous, but it soon crystallizes to form an apatite
hydroxycarbonate organized structure. This compound
attracts collagen fibers, condroitin sulphate, and
FIGURE 6 - PG, 60 days. Thicker lamellar bone trabeculae
surrounding the spaces taken up by glass; interspersed
with bone marrow (A), with indications of bone remodeling.
HE. Magnification 200x
FIGURE 7 - BG, 60 days. Lamellar bone trabeculae
surrounding the spaces filled with glass are thicker. Inside
some spaces, a structure remaining from the implanted
material (A) may be observed amidst the bone tissue,
besides some thin bone septa. Bone growth can be
observed inside the granule (B). HE. Magnification 400x
FIGURE 8 - BG, 60 days. Detail of granule excavation (A)
showing newly formed bone (B) and reticular aspect of the
material.  HE. Magnification 400x
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glycosaminoglycans, which are incorporated into that gel
layer. Osteoblasts are also attracted to this layer; organic
constituents are released, followed by mineralization.
Studying the rabbit femur, Oonish, et al.23, 1996, compared
bioactive glass and synthetic hydroxyapatite (prepared by
sintering at 1200°C in air, then crushed into granules and
sieved to produce particles of 100 to 300-µm diameter), and
demonstrated that the latter presented bone formation with
little density around granules. There was greater bone
formation around bioactive glass granules. After 12 weeks,
particles could not be seen because they were completely
incorporated into the newly formed bone tissue. Results
from this study suggest that bioactive glass particles forming
a cohesive layer over tissues easily remain inside the defect,
even when the site is bleeding, and exceed by far
hydroxyapatite inconveniences in retarding osteogenesis.
This study is in agreement with the present findings, on
which particles were interspersed with a new trabecular bone
at 60 days, with mature lamellar aspect.
In this study, two different types of bioactive glass were
evaluated: Biogran and Perioglas. Both materials are
composed of silica, calcium, sodium and phosphorus, in the
form of oxides. Biogran is a glass material with regular size
particles, 300 to 350ìm, whereas Perioglas presents varying
size particles, 90 to 710ìm. According to Yukna, et al.29, 2001,
more regular particles (300 to 355ìm) are perfect for the
treatment of periodontal bone defects. Zamet, et al.30, 1997,
in a clinical experiment, showed that varying size particles
(90 to 710ìm) have a greater effect and a better gain in the
clinical attachment level.
The present study showed bone formation on both types
of granules. After 60 days, macroscopic verification of the
implanted site was very difficult. There was no difference in
bone formation around and inside fissures formed on
particles from both groups. Both materials were bonded to
adjacent bone tissue, preventing connective tissue
migration; however, they were not osteoinductive. They
acted as a filling material which, according to characteristics
described previously, stimulated osteogenesis, with fissure
or vesicle formation, behaved as an osteogenic nucleus,
with osseointegrated particles, which were not completely
reabsorbed and replaced in the time period investigated.
The osteoprogenitor cells repopulating the graft came from
the bone marrow, and from the endosteum and periosteum
of the defect walls.
The osteogenic characteristic of bioactive glass particles
may be related to the activation of an autocrine mechanism
in osteoblasts, mediated by the induction of secretion of
transforming growth factor-b, as occurs with the mitogenic
effect of soluble silica on osteoblast-like cells in cultures
(Cordioli, et al.4, 2001). Particles release a substantial
concentration of soluble silica, as well as Ca and P, during
the first few days in contact with fluids on the site, which
may be responsible for the osteogenic effects observed in
this study. These particles are then incorporated to the
growing bone as a component, and are used to build new
bone, yet the usefulness of these materials needs to be
elucidated in further clinical studies.
CONCLUSIONS
Considering the results obtained, the following can be
concluded:
- Both materials promoted comparable bone formation
over the entire extension of the defect, independently of
their granules size, thus confirming their biological
osteoconductive property.
- No inflammatory reaction was observed due to the
presence of the implanted materials.
- As a consequence of its osteoconductive and
osseointegration properties, bioactive glass can be
recommended for the treatment of bone defects, either
separately or in combination with other techniques, or in
composition with other bone substitute materials.
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